RE: Shorts27 May 2026 15:48
The drop in share price is possibly due to warrants being exercised. After recent RNS's the total number of warrants before the Capital Growth Facility was as follows.
40,000,000 1.5p 30/06/2028
15,899,999 2p 28/08/2026
2,512,760 5p 9/06/2026
While the 2p warrants were likely to be exercised before late August, there was no rush on the 1.5p warrants, which don't expire until 30th June 2028.
As warrant holder's were not going to gain from the CGF, they may have decided to cash in early to spite the management. However, if all the 1.5p and 2p warrants are exercised, then £725k will be added to REE's bank balance. If the share price bounces strong after an announcement that all the 1.5p and 2p warrants are gone (strong possibility), then the 5p warrants might come into play. The initial 12,000,000 shares of the CGF, if sold above 5p would then add over £600k (good news on the HREE assays and with no warrant sale drag, a share price of 7.5p average would add £900k). The 5p warrants would add over £125k and REE might not require any other tranches of the CGF, as over £1,643k (£1,943k if 7.5p average price met) would gave been raised.